Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Td92, an outer membrane protein of Treponema denticola, induces osteoclastogenesis via prostaglandin E(2)-mediated RANKL/osteoprotegerin regulation.

Kim M, Jun HK, Choi BK, Cha JH, Yoo YJ.

J Periodontal Res. 2010 Dec;45(6):772-9. doi: 10.1111/j.1600-0765.2010.01298.x.

PMID:
20682013
3.

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.

Suda K, Udagawa N, Sato N, Takami M, Itoh K, Woo JT, Takahashi N, Nagai K.

J Immunol. 2004 Feb 15;172(4):2504-10.

4.

Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.

Chung YH, Chang EJ, Kim SJ, Kim HH, Kim HM, Lee SB, Ko JS.

J Periodontal Res. 2006 Aug;41(4):288-96.

PMID:
16827722
5.

Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.

Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y.

Bone. 2007 Aug;41(2):165-74. Epub 2007 May 5.

PMID:
17560185
6.

[Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action].

Wang L, Mao YJ, Wang WJ.

Yao Xue Xue Bao. 2006 Jun;41(6):555-60. Chinese.

PMID:
16927832
7.

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.

Qiang YW, Chen Y, Stephens O, Brown N, Chen B, Epstein J, Barlogie B, Shaughnessy JD Jr.

Blood. 2008 Jul 1;112(1):196-207. doi: 10.1182/blood-2008-01-132134. Epub 2008 Feb 27.

8.

Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.

Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.

J Bone Miner Res. 2000 Sep;15(9):1766-75.

10.

Local osteoprotegerin gene transfer to periodontal tissue inhibits lipopolysaccharide-induced alveolar bone resorption.

Chen R, Kanzaki H, Chiba M, Nishimura M, Kanzaki R, Igarashi K.

J Periodontal Res. 2008 Apr;43(2):237-45. Epub 2007 Dec 12.

PMID:
18086145
11.
12.

Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.

Kim HN, Ha H, Lee JH, Jung K, Yang D, Woo KM, Lee ZH.

Eur J Pharmacol. 2009 Nov 25;623(1-3):22-9. doi: 10.1016/j.ejphar.2009.09.025. Epub 2009 Sep 17.

PMID:
19766111
13.

Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.

Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.

J Bone Miner Res. 2000 Aug;15(8):1459-66.

14.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
15.
16.

Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels.

Kondo T, Kitazawa R, Yamaguchi A, Kitazawa S.

J Cell Biochem. 2008 Jan 1;103(1):335-45.

PMID:
17516544
17.
18.

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.

Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.

Mol Pharmacol. 2010 Jan;77(1):17-25. doi: 10.1124/mol.109.057877. Epub 2009 Oct 14.

19.

Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola.

Choi BK, Lee HJ, Kang JH, Jeong GJ, Min CK, Yoo YJ.

Infect Immun. 2003 Jan;71(1):226-33.

20.

Supplemental Content

Support Center